{"transactions":[{"id":4628708,"issuer":{"id":7487,"kind":"organization","name":"ClearSign Technologies Corp","symbol":"CLIR"},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Statutory Stock Options","published_at":"2026-10-02T23:01:16.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":3766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As compensation for services as a non-employee director during the quarter ended September 30, 2026, the reporting person was granted non-statutory stock options to purchase 3,766 shares of common stock under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date."}],"balance_after":3766,"derivative":{"exercise_price":3.55,"expiration_date":"2036-09-29","underlying":"Common Stock","underlying_shares":3766},"source":{"system":"sec-edgar","filing":"0001104659-26-113417","document":"tm2626853-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000110465926113417/tm2626853-4_4seq1.xml","form_type":"4"}},{"id":718161,"issuer":{"id":7487,"kind":"organization","name":"ClearSign Technologies Corp","symbol":"CLIR"},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Statutory Stock Options","published_at":"2026-07-02T23:01:54.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":4595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As compensation for services as a non-employee director during the quarter ended June 30, 2026, the reporting person was granted non-statutory stock options to purchase 4,595 shares of common stock under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date."}],"balance_after":4595,"derivative":{"exercise_price":3.67,"expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":4595},"source":{"system":"sec-edgar","filing":"0001104659-26-080470","document":"tm2619589-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000110465926080470/tm2619589-3_4seq1.xml","form_type":"4"}},{"id":819757,"issuer":{"id":7487,"kind":"organization","name":"ClearSign Technologies Corp","symbol":"CLIR"},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Statutory Stock Options","published_at":"2026-04-02T23:02:24.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":3024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As compensation for services as a non-employee director during the quarter ended March 31, 2026, the reporting person was granted non-statutory stock options to purchase 3,024 shares of common stock under the ClearSign Technologies Corporation 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date."}],"balance_after":3024,"derivative":{"exercise_price":4.36,"expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":3024},"source":{"system":"sec-edgar","filing":"0001104659-26-039311","document":"tm2610943-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000110465926039311/tm2610943-3_4seq1.xml","form_type":"4"}},{"id":932411,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-24T00:43:04.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":60324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":65709,"source":{"system":"sec-edgar","filing":"0001193125-26-021412","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000119312526021412/ownership.xml","form_type":"4"}},{"id":1024717,"issuer":{"id":7487,"kind":"organization","name":"ClearSign Technologies Corp","symbol":"CLIR"},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-03T22:00:59.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":24621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As compensation for services as a non-executive director during the quarter ending December 31, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting person's death; or (4) the reporting person's separation from service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting person's death; or (4) the reporting person's separation from service."}],"balance_after":70266,"derivative":{"underlying":"Common Stock","underlying_shares":24621},"source":{"system":"sec-edgar","filing":"0001104659-25-096764","document":"tm2527975-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000110465925096764/tm2527975-2_4seq1.xml","form_type":"4"}},{"id":1092589,"issuer":{"id":7487,"kind":"organization","name":"ClearSign Technologies Corp","symbol":"CLIR"},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-07-03T22:45:45.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":34722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As compensation for services as a non-executive director during the quarter ending September 30, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting person's death; or (4) the reporting person's separation from service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting person's death; or (4) the reporting person's separation from service."}],"balance_after":45645,"derivative":{"underlying":"Common Stock","underlying_shares":34722},"source":{"system":"sec-edgar","filing":"0001104659-25-065881","document":"tm2519904-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000110465925065881/tm2519904-1_4seq1.xml","form_type":"4"}},{"id":1097970,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-01T10:26:33.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":5384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026."}],"balance_after":5385,"source":{"system":"sec-edgar","filing":"0000950170-25-091888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000095017025091888/ownership.xml","form_type":"4"}},{"id":1133534,"issuer":{"id":7487,"kind":"organization","name":"ClearSign Technologies Corp","symbol":"CLIR"},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-27T23:06:12.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":10923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As compensation for services as a non-executive director during the quarter ending June 30, 2025, on May 22, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan, pro-rated based on an appointment date of May 22, 2025, and each RSU represents a right to receive one share of common stock or the cash equivalent thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting person's death; or (4) the reporting person's separation from service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting person's death; or (4) the reporting person's separation from service."}],"balance_after":10923,"derivative":{"underlying":"Common Stock","underlying_shares":10923},"source":{"system":"sec-edgar","filing":"0001104659-25-053133","document":"tm2516240-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000110465925053133/tm2516240-3_4seq1.xml","form_type":"4"}},{"id":1622748,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-02-23T22:00:45.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025."}],"balance_after":600,"derivative":{"exercise_price":1.59,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001209191-24-003899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919124003899/doc4.xml","form_type":"4"}},{"id":2038631,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-02-02T01:30:39.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":6746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024."}],"balance_after":6746,"derivative":{"exercise_price":4.02,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":6746},"source":{"system":"sec-edgar","filing":"0001209191-23-006052","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919123006052/doc4.xml","form_type":"4"}},{"id":2314278,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-30T21:15:14.000Z","date":"2022-03-28","kind":"grant","acquired":true,"shares":74500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023."}],"balance_after":74500,"derivative":{"exercise_price":0.38,"expiration_date":"2032-03-28","underlying":"Common Stock","underlying_shares":74500},"source":{"system":"sec-edgar","filing":"0001209191-22-021618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919122021618/doc4.xml","form_type":"4"}},{"id":2449797,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-01-04T22:03:07.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy."}],"balance_after":12000,"derivative":{"exercise_price":0.74,"exercise_date":"2023-01-03","expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-000951","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919122000951/doc4.xml","form_type":"4"}},{"id":2588435,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-27T20:15:10.000Z","date":"2021-08-26","kind":"sale","acquired":false,"shares":5000,"price":1.85,"value":9250.0,"ownership":{"direct":true},"balance_after":49068,"source":{"system":"sec-edgar","filing":"0001209191-21-053613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919121053613/doc4.xml","form_type":"4"}},{"id":2588434,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-27T20:15:10.000Z","date":"2021-08-25","kind":"sale","acquired":false,"shares":45000,"price":1.83,"value":82350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.81 to $1.84, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":54068,"source":{"system":"sec-edgar","filing":"0001209191-21-053613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919121053613/doc4.xml","form_type":"4"}},{"id":2754490,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-04-07T20:13:25.000Z","date":"2021-04-05","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022."}],"balance_after":25000,"derivative":{"exercise_price":2.64,"expiration_date":"2031-04-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-025853","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919121025853/doc4.xml","form_type":"4"}},{"id":2772079,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-03-25T21:01:02.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 4, 2021 pursuant to the Issuer's Non-Employee Director Compensation Policy."}],"balance_after":12000,"derivative":{"exercise_price":0.8,"exercise_date":"2022-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-023042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919121023042/doc4.xml","form_type":"4"}},{"id":3000043,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-26T21:14:49.000Z","date":"2020-10-22","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning on October 22, 2021."}],"balance_after":50000,"derivative":{"exercise_price":0.73,"expiration_date":"2030-10-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-055831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919120055831/doc4.xml","form_type":"4"}},{"id":3129262,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-01T10:27:43.000Z","date":"2020-05-29","kind":"purchase","acquired":true,"shares":10000,"price":0.9,"value":9000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested restricted stock units."}],"balance_after":99068,"source":{"system":"sec-edgar","filing":"0001209191-20-033102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919120033102/doc4.xml","form_type":"4"}},{"id":3130851,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T10:48:22.000Z","date":"2020-05-28","kind":"purchase","acquired":true,"shares":10000,"price":0.91,"value":9100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.89 to $0.92, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested restricted stock units."}],"balance_after":89068,"source":{"system":"sec-edgar","filing":"0001209191-20-032826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919120032826/doc4.xml","form_type":"4"}},{"id":3132423,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-28T10:47:38.000Z","date":"2020-05-27","kind":"purchase","acquired":true,"shares":10000,"price":0.85,"value":8500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested restricted stock units."}],"balance_after":79068,"source":{"system":"sec-edgar","filing":"0001209191-20-032502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919120032502/doc4.xml","form_type":"4"}},{"id":3133988,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-27T11:25:20.000Z","date":"2020-05-26","kind":"purchase","acquired":true,"shares":10000,"price":0.82,"value":8200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested restricted stock units."}],"balance_after":69068,"source":{"system":"sec-edgar","filing":"0001209191-20-032219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919120032219/doc4.xml","form_type":"4"}},{"id":3137532,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T10:17:21.000Z","date":"2020-05-21","kind":"purchase","acquired":true,"shares":10000,"price":0.71,"value":7100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested restricted stock units."}],"balance_after":59068,"source":{"system":"sec-edgar","filing":"0001209191-20-031547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919120031547/doc4.xml","form_type":"4"}},{"id":3176601,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-04-15T20:41:54.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a stock option award granted on April 9, 2020 pursuant to the Issuer's Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option grant becomes exercisable in three equal annual installments beginning April 9, 2021."}],"balance_after":50000,"derivative":{"exercise_price":0.7,"expiration_date":"2030-04-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-024484","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919120024484/doc4.xml","form_type":"4"}},{"id":3176600,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":32915,"kind":"person","name":"Basenese Lou","position":1,"cik":"0001809482","reported_name":"Basenese Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-15T20:41:54.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":41587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director Compensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day of each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested restricted stock units."}],"balance_after":41587,"source":{"system":"sec-edgar","filing":"0001209191-20-024484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809482/000120919120024484/doc4.xml","form_type":"4"}}]}